No Nod For Covaxin Yet, WHO Seeks Additional Clarifications : Report

The World Health Organisation's technical advisory group on Tuesday sought "additional clarifications" from Bharat Biotech for its COVID-19 vaccine Covaxin to conduct a final "risk-benefit assessment" for Emergency Use Listing of the vaccine.

Related Keywords

India ,Bharat ,Margaret Harris ,Johnson Janssen ,Pfizer ,Bio Serum Institute Of India ,Astrazeneca ,Technical Advisory Group ,Technical Advisory Group For Emergency Use Listing ,Oxford University Covishield ,World Health Organisation ,Additional Clarifications ,Bharat Biotech ,Emergency Use Listing ,Oxford University ,Serum Institute ,Covaxin ,Covaxin Coronavirus Vaccine ,